I
BCRX icon

InceptionR’s BioCryst Pharmaceuticals BCRX Stock Holding History

InceptionR’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Buy
+14,624
New +$132K 0.04% 612
2026
Q1 		– Sell
-13,631
Closed -$106K – 653
2025
Q4 		$106K Buy
13,631
+2,317
+20% +$16.8K 0.03% 576
2025
Q3 		$85.9K Sell
11,314
-664
-6% -$5.53K 0.02% 638
2025
Q2 		$107K Buy
+11,978
New +$112K 0.02% 611
2024
Q4 		– Sell
-31,826
Closed -$242K – 625
2024
Q3 		$242K Buy
31,826
+21,688
+214% +$165K 0.06% 523
2024
Q2 		$62.7K Buy
+10,138
New +$55.9K 0.02% 555

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

InceptionR's BCRX Position: Q2 2026 in Review

InceptionR opened a new position in BioCryst Pharmaceuticals (BCRX) in Q2 2026: 14,624 shares worth $146K. The stake represents 0.04% of the portfolio and ranks #612 among its holdings. This is a return to the name: InceptionR previously reported a position in BCRX as recently as Q4 2025.

InceptionR first reported a position in BCRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $242K in Q3 2024. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • InceptionR held 14,624 shares of BioCryst Pharmaceuticals worth $146K as of Q2 2026.
  • BioCryst Pharmaceuticals was a new InceptionR position in Q2 2026.
  • BioCryst Pharmaceuticals made up 0.04% of InceptionR's portfolio in Q2 2026, its #612 holding.
  • InceptionR first reported a position in BioCryst Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • InceptionR's BioCryst Pharmaceuticals position peaked at $242K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.